As cancer treatments continue to advance, more individuals are living longer after their initial diagnosis. This progress has shifted clinical focus toward cancer survivorship and the long-term management of physical, metabolic, and emotional health. Modern survivorship care involves a coordinated approach to address not only the potential return of disease, but also the delayed effects of therapies and concurrent medical conditions [1], [2].
The Role of Primary Care in Post-Treatment Support
Following the completion of primary cancer therapy, ongoing medical oversight is essential. Research examining post-treatment care patterns among breast cancer survivors indicates that approximately 72% receive primary care provider (PCP)-led follow-up, though engagement rates can vary across different age groups and demographics [1]. Primary care professionals play a vital role in optimizing the management of co-existing medical conditions and coordinating specialized services [1]. Improving access and strengthening support for primary care engagement remain key objectives for optimizing long-term survivorship outcomes [1].
Managing New Complications and Oncoendocrinology
Innovative oncology treatments—including immune checkpoint inhibitors, targeted therapies, CAR T-cell therapy, and antibody-drug conjugates—have significantly improved survival rates [2]. However, these powerful therapies can introduce a distinct spectrum of late-onset metabolic and endocrine complications [2]. These therapy-induced conditions may include:
- Thyroid dysfunction and adrenal insufficiency
- New-onset diabetes and dyslipidemia
- Metabolic syndrome and gonadal dysfunction
- Hypophysitis and pancreatitis
Unlike traditional endocrine disorders, these treatment-related issues can appear abruptly and present with atypical clinical patterns, requiring specialized multidisciplinary management within the emerging field of oncoendocrinology [2].
Monitoring Recurrence and Long-Term Surveillance
Long-term follow-up protocols are tailored to the specific type of malignancy and individual risk factors. For instance, studies evaluating long-term outcomes following curative treatments—such as endoscopic resections for early gastric neoplasia or surgical management of differentiated thyroid cancer—demonstrate that structured surveillance is necessary to detect late recurrences or secondary lesions [3], [7]. Recognizing patient-specific risk profiles allows clinical teams to design appropriate monitoring schedules that balance thorough surveillance with patient quality of life.
Addressing Complex Health Histories
Survivorship care also intersects with pre-existing or concurrent neurological and chronic conditions. Real-world observational data involving individuals with multiple sclerosis who have undergone cancer treatment show that coordinated management helps clinicians navigate complex medication regimens, monitor relapse risks, and support ongoing disability tracking [5]. Comprehensive survivorship programs account for these overlapping health complexities to ensure safe and continuous care.
Sources
- 1. Characterizing primary care in breast cancer survivors after completion of cancer therapy. PubMed
- 2. The Rise of Oncoendocrinology: How Modern Cancer Therapies Are Reshaping Endocrine Practice. PubMed
- 3. Follow-up study of the treatment of patients operated on for differentiated thyroid cancer - a 30-year single-center study. PubMed
- 4. Long-Term Observational Extension Study of an International Stroke Prevention Clinical Trial: Methods and Opportunities. PubMed
- 5. Multiple sclerosis outcomes after cancer diagnosis in people with recorded chemotherapy exposure: A real-world MSBase study. PubMed
- 6. Adjuvant apatinib therapy following concurrent chemoradiotherapy in patients with high-risk nasopharyngeal carcinoma: A multicenter, prospective phase 2 study. PubMed
- 7. Long-term and second recurrence following curative ESD for synchronous multiple early gastric neoplasia: a single-center cohort study. PubMed
- 8. Effect of a nurse-led follow-up program on the health-related quality of life among patients with heart failure: A randomized clinical trial. PubMed